Research / CDLX / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-26-053340 General Corporate
Debt relative to revenue 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
500.00% · OPTIONAL · VALID
Capex intensity 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.01% · OPTIONAL · VALID
Operating cash generation 15th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-23.31% · OPTIONAL · VALID
Revenue growth 5th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-36.46% · CORE · VALID
Operating margin 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-14.75% · CORE · VALID
R&D intensity 5th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
15.02% · OPTIONAL · VALID
SBC intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
6.39% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 29 states Self-history eligible
Sep 30, 2021 4/4 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Dec 31, 2021 6/6 normalized Amended as filed Mar 31, 2022 6/6 normalized Level 3 Sep 30, 2022 6/6 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 595.01%
Current 500.00%
Delta -95.01% Capex Intensity Decreased
Previous 0.08%
Current 0.01%
Delta -0.08% Cash Generation Decreased
Previous -16.44%
Current -23.31%
Delta -6.87% Growth Increased
Previous -39.19%
Current -36.46%
Delta 2.73% Profitability Increased
Previous -24.11%
Current -14.75%
Delta 9.36% R And D Intensity Decreased
Previous 18.74%
Current 15.02%
Delta -3.72% Sbc Intensity Decreased
Previous 14.07%
Current 6.39%
Delta -7.68% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Mar 31, 2026
Similarity 80%
Compared 7 dimensions
Coverage 100% Growth 5.0 · Profitability 5.0 · Sbc Intensity 40.0 · Capex Intensity 10.0 · Cash Generation 15.0 · R And D Intensity 30.0 · Balance Sheet Leverage 5.0 Mar 31, 2023
Similarity 66%
Compared 7 dimensions
Coverage 100% Growth 16.4 · Profitability 10.0 · Sbc Intensity 35.0 · Capex Intensity 6.1 · Cash Generation 12.8 · R And D Intensity 80.0 · Balance Sheet Leverage 5.0 Mar 31, 2025
Similarity 65%
Compared 7 dimensions
Coverage 100% Growth 25.0 · Profitability 5.0 · Sbc Intensity 35.0 · Capex Intensity 5.0 · Cash Generation 30.0 · R And D Intensity 75.0 · Balance Sheet Leverage 5.0 Sep 30, 2022
Similarity 60%
Compared 6 dimensions
Coverage 86% Growth 20.0 · Profitability 9.4 · Sbc Intensity 16.7 · Capex Intensity 5.0 · Cash Generation 3.8 · R And D Intensity 95.0 Sep 30, 2025
Similarity 58%
Compared 7 dimensions
Coverage 100% Growth 0.0 · Profitability 70.0 · Sbc Intensity 25.0 · Capex Intensity 0.0 · Cash Generation 75.0 · R And D Intensity 35.0 · Balance Sheet Leverage 5.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.